Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,268,560 papers from all fields of science
Search
Sign In
Create Free Account
S 5682
Known as:
S-5682
, S5682
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Daflon
Detralex
Broader (3)
Diosmin
Drug Combinations
Hesperidin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Effects of oral administration of different doses of purified micronized flavonoid fraction on microvascular reactivity after ischaemia/reperfusion in the hamster cheek pouch
E. Bouskela
,
F. Cyrino
,
L. Lerond
British Journal of Pharmacology
1997
Corpus ID: 44720576
1 The effects of a purified micronized flavonoid fraction (S5682) on mean internal diameter and blood flow of arterioles and…
Expand
1997
1997
Oxidant-induced increase in vascular permeability is inhibited by oral administration of S-5682 (Daflon 500 mg) and alpha-tocopherol.
E. Bouskela
,
Erik Svensjö
,
F. Cyrino
,
L. Lerond
International journal of microcirculation…
1997
Corpus ID: 41798695
The aim was to study the effect of oral administration of three different doses of S-5682 and alpha-tocopherol on an oxidant…
Expand
1997
1997
Microvascular Reactivity After Ischemia/Reperfusion in the Hamster Cheek Pouch: Beneficial Effects of Different Oral Doses of S-5682 (Daflon 500 mg)
E. Bouskela
,
F. Cyrino
,
L. Lerond
Angiology
1997
Corpus ID: 19727051
Daflon 500 mg (S-5682) is a purified, micronized flavonoid fraction containing 90% diosmin and 10% hesperidin that is currently…
Expand
1995
1995
Effects of oral administration of purified micronized flavonoid fraction on increased microvascular permeability induced by various agents and on ischemia/reperfusion in diabetic hamsters.
Eliete Bouskela
,
K. A. Donyo
International journal of microcirculation…
1995
Corpus ID: 825240
The effects of a clinically used purified micronized flavonoid fraction (S5682) containing 90% diosmin and 10% hesperidin on…
Expand
Highly Cited
1993
Highly Cited
1993
A double-blind, placebo-controlled trial of a new veno-active flavonoid fraction (S 5682) in the treatment of symptomatic capillary fragility.
P. Galley
,
M. Thiollet
International Angiology
1993
Corpus ID: 45371084
The efficacy and safety of a new veno-active flavonoid fraction (S 5682) consisting of micronized diosmin (90%) and hesperidin…
Expand
1993
1993
Antioxidant activity of micronized diosmin on oxygen species from stimulated human neutrophils.
MARIE-LUCE Carrie
Biochemical Pharmacology
1993
Corpus ID: 2545281
Highly Cited
1989
Highly Cited
1989
Protective effect of a purified flavonoid fraction against reactive oxygen radicals. In vivo and in vitro study.
M. Lonchampt
,
B. Guardiola
,
N. Sicot
,
M. Bertrand
,
L. Perdrix
,
J. Duhault
Arzneimittel-Forschung
1989
Corpus ID: 36503770
S 5682 is a purified flavonoid fraction containing 90% diosmin (flavone derivative) and 10% hesperidin (flavanone derivative). In…
Expand
1988
1988
Action of S 5682 on the complement system. In vitro and in vivo study.
T. Di Perri
,
A. Auteri
International Angiology
1988
Corpus ID: 45891273
Activation of the complement system during the early phase of inflammation is partly responsible for increased vascular…
Expand
1988
1988
Effect of a flavonoid preparation (S 5682) on experimental capillary permeability increase in rat paw and rabbit skin.
T. Godfraind
International Angiology
1988
Corpus ID: 23631250
S 5682 is constituted by a flavonoid mixture of 90% diosmin and 10% hesperidin. Its action has been studied in vivo on…
Expand
Highly Cited
1987
Highly Cited
1987
Effect of chronic treatment with a purified flavonoid fraction on inflammatory granuloma in the rat. Study of prostaglandin E2 and F2 alpha and thromboxane B2 release and histological changes.
M. Damon
,
O. Flandre
,
F. Michel
,
L. Perdrix
,
C. Labrid
,
A. Crastes de Paulet
Arzneimittel-Forschung
1987
Corpus ID: 24561104
S-5682 (Daflon-500 mg), a purified flavonoid fraction, consisting of 90% diosmin (a flavone derivative) and 10% hesperidin (a…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE